AlphaYouRC
Schedule 13G filing
Readout Capital, LP disclosed a 5.4% stake in TScan Therapeutics, Inc. (TCRX)
Readout Capital, LP reported owning 5.4% of TScan Therapeutics, Inc. (TCRX) (3,453,388 shares) in a Schedule 13G filed Sep 25, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 25, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.